Decreased RECK and Increased EMMPRIN Expression in Urothelial Carcinoma of the Bladder Are Associated with Tumor Aggressiveness
Authors:
- Albrecht StenzingerASAlbrecht Stenzinger
- Frederick KlauschenFKFrederick Klauschen
- Carsten StephanCSCarsten Stephan
- Klaus JungKJKlaus Jung
- Andreas ErbersdoblerAEAndreas Erbersdobler
- Anja RabienARAnja Rabien
- 26 May 2011
- journal article
- Published by S. Karger AG in Pathobiology
- Vol. 78 (3) , 123-131
Abstract
Objective: Urothelial bladder carcinomas show a divergent biological behavior, which significantly complicates risk stratification and clinical management. The MMP repressor RECK and the MMP activator EMMPRIN regulate the invasive potential by metalloproteinase-induced stromal degradation. Data on RECK in urothelial bladder cancer are lacking and information on EMMPRIN is sparse. This study aims to investigate the expression of RECK and EMMPRIN in urothelial carcinoma of the bladder and to correlate these findings with clinicopathological parameters. Methods: Our study included 127 specimens of urothelial carcinomas derived from 103 patients who underwent either TUR-B or cystectomy. Immunohistochemical expression analysis was performed for RECK, EMMPRIN, MMP-2, MMP-9 and MMP-14. Expression levels were graded for staining intensity and correlated with pT stage and WHO tumor grade. Results: Invasive (≧pT1) as well as WHO high-grade urothelial carcinomas showed a statistically significant and stepwise downregulation of RECK (p < 0.001) and concomitant upregulation of EMMPRIN (p < 0.001) compared to non-invasive and WHO low-grade tumors. No correlation was observed for the MMPs investigated. Conclusion: Decreased RECK and increased EMMPRIN expression are associated with increasing stage and grade. Both proteins may serve as molecular marker for the distinction between potentially invasive (≧pT1) and non-invasive tumors (≤pTa).Keywords
This publication has 37 references indexed in Scilit:
- The membrane-anchored metalloproteinase regulator RECK stabilizes focal adhesions and anterior–posterior polarity in fibroblastsOncogene, 2009
- RECK—a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancerCancer and Metastasis Reviews, 2007
- Recklessness as a hallmark of aggressive cancerCancer Science, 2007
- Correlation of matrix metalloproteinase suppressor genes RECK, VEGF, and CD105 with angiogenesis and biological behavior in esophageal squamous cell carcinomaWorld Journal of Gastroenterology, 2007
- The Predictive Value of p53, p27Kip1, and α-Catenin for Progression in Superficial Bladder CarcinomaEuropean Urology, 2006
- HER-2/neu Represses the Metastasis Suppressor RECK via ERK and Sp Transcription Factors to Promote Cell InvasionJournal of Biological Chemistry, 2006
- Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomyThe Prostate, 2004
- Matrix metalloproteinase inhibitor reversion‐inducing cysteine‐rich protein with Kazal motifsCancer, 2003
- Reck Gene Expression in Hepatocellular Carcinoma: Correlation With Invasion–Related Clinicopathological Factors and Its Clinical SignificanceHepatology, 2001
- Involvement of the Sp1 Site in ras-Mediated Downregulation of the RECK Metastasis Suppressor GeneBiochemical and Biophysical Research Communications, 1999